date/time interval
- May 25, 2020 - December 31, 2026
Evaluating the Magnitude and Distribution of the IFN Signature (Biopharma with AstraZeneca)
Grant
Overview
awarded by
administered by
sponsor award ID
- AZP 211595-01
Affiliation
contributor
- Pascual, Virginia Principal Investigator 2020 - 2022